Cargando…
Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
Autor principal: | White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837842/ https://www.ncbi.nlm.nih.gov/pubmed/24002099 http://dx.doi.org/10.1128/AAC.00287-13 |
Ejemplares similares
-
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents
por: Rizk, M. L., et al.
Publicado: (2019) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand
por: Tarning, J, et al.
Publicado: (2014) -
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
por: Leung, Elizabeth, et al.
Publicado: (2021) -
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017) -
Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development
por: Abd-Rahman, Azrin N., et al.
Publicado: (2022)